Wellington Management Group’s Xeris Biopharma Holdings XERS Stock Holding History

Wellington Management Group’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.6M	Sell	2,171,354 -115,244	-5%	-$764K	﹤0.01%	1176
2025 Q4	$17.9M	Buy	2,286,598 +1,705,636	+294%	+$13.4M	﹤0.01%	1075
2025 Q3	$4.73M	Buy	580,962 +181,671	+45%	+$1.21M	﹤0.01%	1456
2025 Q2	$1.86M	Buy	399,291 +7,192	+2%	+$33K	﹤0.01%	1593
2025 Q1	$2.15M	Sell	392,099 -73,013	-16%	-$295K	﹤0.01%	1539
2024 Q4	$1.58M	Sell	465,112 -6,532	-1%	-$21K	﹤0.01%	1629
2024 Q3	$1.34M	Buy	471,644 +49,535	+12%	+$127K	﹤0.01%	1659
2024 Q2	$950K	Buy	422,109 +25,164	+6%	+$50.7K	﹤0.01%	1686
2024 Q1	$877K	Buy	+396,945	New	+$1.03M	﹤0.01%	1713
2018 Q3	–	Sell	-33,333	Closed	-$633K	–	2322
2018 Q2	$633K	Buy	+33,333	New	+$648K	﹤0.01%	1978

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group's XERS Position: Q1 2026 in Review

Wellington Management Group reduced its Xeris Biopharma Holdings (XERS) stake by 5% in Q1 2026, selling an estimated $764K and leaving 2,171,354 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Wellington Management Group first reported a position in XERS in Q2 2018 and has held it in 10 quarters since. The position peaked at $17.9M in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

Wellington Management Group held 2,171,354 shares of Xeris Biopharma Holdings worth $12.6M as of Q1 2026.
Wellington Management Group sold 115,244 Xeris Biopharma Holdings shares in Q1 2026, an estimated $764K.
Xeris Biopharma Holdings made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1176 holding.
Wellington Management Group first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 10 quarters since.
Wellington Management Group's Xeris Biopharma Holdings position peaked at $17.9M in Q4 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.